Nova Leap Health Corp. Re-engages Acquisition Program with Closing of Strategic Acquisition in Massachusetts
May 06, 2024 08:40 ET
|
Nova Leap Health Corp.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 06, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or...
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
May 06, 2024 08:00 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, has opened its Operations and Manufacturing Center of Excellence in...
Ouverture du centre technologique Eviden Mission Critical Systems à Prottes, en Basse-Autriche
May 06, 2024 04:00 ET
|
Atos International
Eviden renforce sa présence mondiale pour soutenir et accompagner ses clients Paris et Vienne, le 6 mai 2024 - Eviden, la ligne d’activités d’Atos leader dans le digital, le cloud, le big...
Eviden Mission Critical Systems Technology Center opened in Prottes, Lower Austria
May 06, 2024 04:00 ET
|
Atos International
Eviden expands global presence for customers’ core missions Paris and Vienna, May 6 2024 – Eviden, the Atos Group business leading in digital, cloud, big data and security, is pleased...
Correction: Final Results
May 03, 2024 13:10 ET
|
Octopus Titan VCT plc
This announcement replaces the Final Results announcement released at 18:00 on 24 April 2024 which included an incorrect reference to the dividend being paid on 24 May 2024 to shareholders on the...
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Customers Whose Personal Data May Have Been Compromised By The Continuum Health Alliance, LLC Data Breach
May 02, 2024 14:37 ET
|
Edelson Lechtzin LLP
Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Continuum Health Alliance, LLC.
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
May 02, 2024 08:00 ET
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass. and SHANGHAI, China, May 02, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Shanghai KR Pharmtech, a leading company providing...
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
May 02, 2024 07:00 ET
|
Organogenesis Holdings Inc.
Statistically significant (p=0.0177) reduction in knee pain at six monthsStatistically significant (p<0.0001) maintenance of function at six monthsTransformational opportunity for Organogenesis to...
Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment
May 02, 2024 06:30 ET
|
Compass Pathways; Mindful Health Solutions
LONDON, May 02, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental...
Introducing Eviden's new AI computing portfolio - the ultimate solution to unlock AI’s full potential
May 02, 2024 04:00 ET
|
Atos International
Press Release Introducing Eviden's new AI computing portfolio - the ultimate solution to unlock AI’s full potential Paris, France – May 2, 2024 – Eviden, the Atos Group business...